***Due to reaching capacity registration is now closed for this event, if you have already registered and have any queries please email alicia@onenucleus.com***

This event will gather executives from biotech, investment and pharma to share ideas on funding and supporting the next generation of innovation in biotech. There will be two panel discussions moderated by key stakeholders as follows:

17.00 – Arrival and registration
17.30 – Welcome from hosts
17.40 – Panel 1 – Funding the next generation of biotech innovation
Panel:
- Laura Lane, Vice President – Venture Sciences (Europe), Eli Lilly & Company (Moderator)
- Dina Chaya, Partner, Orbimed
- Laurence Barker, Partner, Dementia Discovery Fund (DDF) – SV Health Investors
- Nooman Haque, Partner, Sofinnova
- Claire Brown, Partner, Oxford Sciences

18.20 – Short break
18:50 – Panel 2 – Broadening the scope of external innovation at Lilly
Panel:
- Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics (Moderator)
- Becky Canter, SD, Neuroscience S&E, Eli Lilly & Company
- Lisa Broad, VP, Neuroscience Research, Eli Lilly & Company
- Hugh Nuthall, SD, Neuroscience S&E, Eli Lilly & Company
- Tom Hopkins, VP, ExploR&D, Eli Lilly & Company

19.30 – Drinks/Networking
20.30 – Close

Free to attend.